PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan.\', \'Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.\', \'R&D, Cellspect Co., Ltd., Morioka City, Iwate, Japan.\', \'Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.\', \'Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki City, Nagasaki, Japan.\', \'Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan.\', \'Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki City, Nagasaki, Japan.\', \'Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.\', \'Nagasaki University, Nagasaki City, Nagasaki, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0257452
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34582459
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Performance of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients: A retrospective study in outbreak on a cruise ship.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all